James Balsley

7.3k total citations · 3 hit papers
13 papers, 5.2k citations indexed

About

James Balsley is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, James Balsley has authored 13 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 6 papers in Virology. Recurrent topics in James Balsley's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). James Balsley is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (6 papers) and HIV/AIDS drug development and treatment (6 papers). James Balsley collaborates with scholars based in United States, Cameroon and France. James Balsley's co-authors include Edward M. Connor, Richard D. Gelber, Mary Jo O’Sullivan, Rhoda Sperling, Eleanor Jiménez, Robert W. Coombs, Gwendolyn B. Scott, Pamela Stratton, Edward H. O'Neill and William T. Shearer and has published in prestigious journals such as New England Journal of Medicine, Blood and The American Journal of Medicine.

In The Last Decade

James Balsley

13 papers receiving 4.9k citations

Hit Papers

Reduction of Maternal-Infant Transmission of Human Immuno... 1994 2026 2004 2015 1994 1995 1996 500 1000 1.5k 2.0k 2.5k

Peers

James Balsley
Gwendolyn B. Scott United States
Nathan Shaffer United States
Marc Bulterys United States
Alan E. Greenberg United States
Eleanor Jiménez United States
Mary Elkins United States
Gwendolyn B. Scott United States
James Balsley
Citations per year, relative to James Balsley James Balsley (= 1×) peers Gwendolyn B. Scott

Countries citing papers authored by James Balsley

Since Specialization
Citations

This map shows the geographic impact of James Balsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Balsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Balsley more than expected).

Fields of papers citing papers by James Balsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Balsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Balsley. The network helps show where James Balsley may publish in the future.

Co-authorship network of co-authors of James Balsley

This figure shows the co-authorship network connecting the top 25 collaborators of James Balsley. A scholar is included among the top collaborators of James Balsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Balsley. James Balsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Evans, Thomas G., William Bonnez, Robert C. Rose, et al.. (2001). A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers. The Journal of Infectious Diseases. 183(10). 1485–1493. 150 indexed citations
2.
Boeckh, Michael, et al.. (2001). Phase 1 Evaluation of the Respiratory Syncytial Virus–Specific Monoclonal Antibody Palivizumab in Recipients of Hematopoietic Stem Cell Transplants. The Journal of Infectious Diseases. 184(3). 350–354. 130 indexed citations
3.
Malley, Richard, John P. DeVincenzo, Octavio Ramilo, et al.. (1998). Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein. The Journal of Infectious Diseases. 178(6). 1555–1561. 178 indexed citations
4.
DeVincenzo, John P., Richard Malley, Octavio Ramilo, et al.. (1998). Viral Concentration in Upper and Lower Respiratory Secretions from Respiratory Syncytial Virus (RSV) Infected Children Treated with RSV Monoclonal Antibody (MEDI-493) † 830. Pediatric Research. 43. 144–144. 3 indexed citations
5.
Balsley, James. (1997). Efficacy of zidovudine in preventing HIV transmission from mother to infant. The American Journal of Medicine. 102(5). 45–46. 8 indexed citations
6.
Sperling, Rhoda, David E. Shapiro, Robert W. Coombs, et al.. (1996). Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant. New England Journal of Medicine. 335(22). 1621–1629. 587 indexed citations breakdown →
7.
Connor, Edward M., Rhoda Sperling, Richard D. Gelber, et al.. (1995). Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment. Obstetrical & Gynecological Survey. 50(4). 253–255. 1387 indexed citations breakdown →
8.
Connor, Edward M., P. A. Pizzo, Frank M. Balis, et al.. (1994). Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. 5(1). 20–32. 25 indexed citations
9.
Connor, Edward M., Rhoda Sperling, Richard D. Gelber, et al.. (1994). Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment. New England Journal of Medicine. 331(18). 1173–1180. 2509 indexed citations breakdown →
11.
O’Sullivan, Mary J., Pamela Boyer, Gwendolyn B. Scott, et al.. (1993). The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082). American Journal of Obstetrics and Gynecology. 168(5). 1510–1516. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026